John Mitchell

John Mitchell is a dedicated professional with over 20 years of experience in operations, quality assurance, and laboratory roles within the biopharma and environmental sectors. Currently serving as the Global Site Operations Lead for Cell & Individualized Therapies at Roche, they previously held senior positions at Bristol Myers Squibb and Juno Therapeutics, where they coordinated complex apheresis operations for CAR T therapies across multiple countries. John’s early career included roles in environmental analysis and quality assurance, demonstrating a strong foundation in analytical thinking and project management. They pursued a Bachelor of Science in Chemistry from the University of Stirling and completed a certificate in Project Management from the University of Washington.